Literature DB >> 1537383

Transgenic T cell receptor interactions in the lymphoproliferative and autoimmune syndromes of lpr and gld mutant mice.

C L Sidman1, J D Marshall, H Von Boehmer.   

Abstract

To investigate the role of T cell receptor (TcR) expression and interactions in development of lymphoproliferation and autoimmunity in lpr and gld mutant mice, and to determine whether these autoimmune mutations affect T cell selection and repertoire formation, we generated mice homozygous for either the gld or the lpr mutation and containing TcR alpha/beta transgenes (Von Boehmer, H., Annu. Rev. Immunol. 1990. 8: 531) specific for the male (H-Y) antigen in the context of H-2Db. Four main results emerged from analysis of these mice. First, expression of transgenic TcR had no effect on disease incidence and progression. Second, the accumulating T cells reflected normal processes of positive and negative selection. Third, cells expressing the transgenic TcR participated equally in lymphoproliferation regardless of whether their antigenic peptide and/or presenting major histocompatibility complex molecules were present or not. Fourth, expression of the TcR transgenes markedly altered the phenotype of the major accumulating lymphocyte subset. Thus, in these models of lymphoproliferation and autoimmunity. T cell repertoire formation proceeds normally, specific T cell recognition of antigen has no effect on the participation of individual clones, and the phenotype of the cells accumulating is sensitive to either the timing or the amount of TcR expression. These results are discussed in the context of the primary cause vs. secondary manifestations of autoimmunity in these models.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1537383     DOI: 10.1002/eji.1830220231

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  28 in total

1.  Kinetics of Fas-induced apoptosis in thymic organ culture.

Authors:  T Zhou; M Fleck; U Müeller-Ladner; P Yang; Z Wang; S Gay; S Matsumoto; J D Mountz
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

2.  Proliferation of CD3+ B220- single-positive normal T cells was suppressed in B-cell-deficient lpr mice.

Authors:  T Akashi; S Nagafuchi; K Anzai; D Kitamura; J Wang; I Taniuchi; Y Niho; T Watanabe
Journal:  Immunology       Date:  1998-02       Impact factor: 7.397

3.  A dominant interfering mutant of FADD/MORT1 enhances deletion of autoreactive thymocytes and inhibits proliferation of mature T lymphocytes.

Authors:  K Newton; A W Harris; M L Bath; K G Smith; A Strasser
Journal:  EMBO J       Date:  1998-02-02       Impact factor: 11.598

4.  Effects of antigen presentation on superantigen-induced apoptosis mediated by Fas/Fas ligand interactions in human T cells.

Authors:  M Boshell; J McLeod; L Walker; N Hall; Y Patel; D Sansom
Journal:  Immunology       Date:  1996-04       Impact factor: 7.397

Review 5.  Clinical effects of mutations to CD95 (Fas): relevance to autoimmunity?

Authors:  J P de Villartay; F Rieux-Laucat; A Fischer; F Le Deist
Journal:  Springer Semin Immunopathol       Date:  1998

6.  Interferon-regulatory factors during development of CD4 and CD8 thymocytes.

Authors:  A K Simon; M Desrois; A M Schmitt-Verhulst
Journal:  Immunology       Date:  1997-07       Impact factor: 7.397

7.  Influence of the lpr environment on the lymph node cell phenotypes in C57BL/6 nubg and nulpr chimeras.

Authors:  F Tiberghien; R Ceredig; F Loor
Journal:  Immunology       Date:  1994-12       Impact factor: 7.397

Review 8.  The many roles of FAS receptor signaling in the immune system.

Authors:  Andreas Strasser; Philipp J Jost; Shigekazu Nagata
Journal:  Immunity       Date:  2009-02-20       Impact factor: 31.745

9.  Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice.

Authors:  M Adachi; R Watanabe-Fukunaga; S Nagata
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway.

Authors:  F Weih; R P Ryseck; L Chen; R Bravo
Journal:  Proc Natl Acad Sci U S A       Date:  1996-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.